{"id":2168,"date":"2026-06-08T20:00:00","date_gmt":"2026-06-08T23:00:00","guid":{"rendered":"https:\/\/sevenresiduosaude.com.br\/blog\/?p=2168"},"modified":"2026-06-08T20:00:00","modified_gmt":"2026-06-08T23:00:00","slug":"rss-diagnostico-molecular-pcr-digital-ngs-illumina-ctdna-ctc-mrd-foundation-medicine-guardant360","status":"publish","type":"post","link":"https:\/\/sevenresiduosaude.com.br\/blog\/rss-diagnostico-molecular-pcr-digital-ngs-illumina-ctdna-ctc-mrd-foundation-medicine-guardant360\/","title":{"rendered":"RSS diagn\u00f3stico molecular: PCR, NGS, ctDNA"},"content":{"rendered":"

A regula\u00e7\u00e3o brasileira de RSS \u00e9 frequentemente desafiada por gestores de centros de diagn\u00f3stico molecular. Em 2026, h\u00e1 uma demanda crescente de hospitais com unidade molecular pathology + clinical genomics \u2014 NGS Next-Generation Sequencing<\/strong> Illumina NovaSeq X+ + NextSeq 2000 + MiSeq + iSeq + NovaSeq 6000 R$ 350k-3M equipamento + reagente kit, PCR digital dPCR<\/strong> Bio-Rad QX200 \/ Stilla Naica + qPCR real-time<\/strong> Applied Biosystems QuantStudio + Roche LightCycler + Bio-Rad CFX para COVID\/HCV\/HBV\/HIV\/oncol\u00f3gico, FoundationOne CDx<\/strong> Roche\/Foundation Medicine 324-gene tumor profiling R$ 12-25k\/teste + Guardant360<\/strong> Guardant Health ctDNA liquid biopsy 74-83 genes R$ 8-18k\/teste, MRD Minimal Residual Disease<\/strong> Adaptive clonoSEQ IGH\/TCR para LLA + Natera Signatera tumor-informed ctDNA + Foundation Tracker, CTC Circulating Tumor Cells<\/strong> CellSearch Veridex + Parsortix Angle + Vortex BioSciences microfluidic, MSI Microsatellite Instability + TMB Tumor Mutational Burden + HRD Homologous Recombination Deficiency<\/strong> + companion diagnostics CDx, liquid biopsy ctDNA cell-free DNA cfDNA<\/strong> Grail Galleri + Exact Sciences Cologuard multi-cancer screening, FISH Fluorescence In Situ Hybridization<\/strong> + IHC Immunohistochemistry + RT-PCR fusion + multiplex Olink + Singulex digital, Sanger sequencing<\/strong> cl\u00e1ssico + capillary + microarray + nanopore Oxford MinION + PacBio Sequel IIe long-read, CRISPR diagnostics SHERLOCK + DETECTR<\/strong> + LAMP isothermal + Sherlock Cas13 detector. A consequ\u00eancia \u00e9 a urg\u00eancia de PGRSS dedicado para diagn\u00f3stico molecular<\/strong> \u2014 captura de kit reagente NGS Illumina<\/strong> TruSight Oncology + TruSeq + NovaSeq X reagent cartridge + flow cell R$ 4-50k\/run + descarte espec\u00edfico bioactive + EPI lab BSL-2\/3 + biosseguran\u00e7a Lei 11.105, kit FoundationOne CDx Roche<\/strong> + Guardant360 + Signatera Natera + clonoSEQ Adaptive + Veracyte tumor profile + Tempus xR teste descart\u00e1vel R$ 8-25k\/teste + LGPD gen\u00e9tico + Lei 14.510 + Resolu\u00e7\u00e3o CFM 1.999, microc\u00e1psula PCR digital Bio-Rad QX200<\/strong> + chip Stilla Naica<\/strong> descart\u00e1veis R$ 200-800\/teste + reagente master mix, CellSearch Veridex<\/strong> ferromagnetic beads + EpCAM antibody + an\u00e1lise CTC + Parsortix microfluidic Angle<\/strong> R$ 4-12k\/teste, bioinform\u00e1tica + storage<\/strong> com 1-3TB\/paciente NGS + servidor + cloud GCP\/AWS Genomics + LGPD + criptografia AES-256, EPI lab BSL-2\/3 biosseguran\u00e7a<\/strong> Lei 11.105 + macac\u00e3o Tyvek + capacete + face shield + cabine fluxo laminar Class II + autoclave A1 + livro CTNBio se OGM\/transg\u00eanico, descarte FFPE bloco parafina<\/strong> + xileno + corante histopatologia + l\u00e2mina + lam\u00ednula. A realidade \u00e9 que diag molecular produz RSS de alt\u00edssima especializa\u00e7\u00e3o. PGRSS de diag molecular \u00e9 cadeia integrada<\/strong> \u2014 come\u00e7a na pr\u00e9-anal\u00edtica<\/strong> (coleta + FFPE + cfDNA tube + transporte cadeia fria), passa pela anal\u00edtica<\/strong> (NGS + PCR + Sanger + microarray) e termina na p\u00f3s-anal\u00edtica<\/strong> (bioinform\u00e1tica + LGPD gen\u00e9tico + reporte). O conjunto soma R$ 25.000-58.000\/m\u00eas<\/strong> que muitos gestores subestimam.<\/p>\n

Para o gestor que opera ou planeja unidade diag molecular, \u00e9 fundamental considerar a complexidade desde o in\u00edcio.<\/p>\n

Os procedimentos diagn\u00f3stico molecular e os RSS espec\u00edficos<\/h2>\n

Em uma opera\u00e7\u00e3o de qualquer porte, a cadeia gera RSS espec\u00edficos.<\/p>\n\n\n\n\n\n\n\n\n\n
Procedimento<\/th>\nInsumo cr\u00edtico<\/th>\nAn\u00e1lise<\/th>\nRisco RSS<\/th>\n<\/tr>\n<\/thead>\n
NGS Illumina NovaSeq X<\/td>\nReagent cartridge + flow cell<\/td>\nTumor profile 324-gene<\/td>\nA4 + B + biol\u00f3gico BSL-2<\/td>\n<\/tr>\n
FoundationOne CDx<\/td>\nBloco FFPE+kit Roche<\/td>\n324 gene tumor profiling<\/td>\nA4 + B Lista C5 + LGPD<\/td>\n<\/tr>\n
ctDNA Guardant360<\/td>\nCell-free DNA tube + 10mL<\/td>\nLiquid biopsy 74-83 genes<\/td>\nA1 + B + LGPD gen\u00e9tico<\/td>\n<\/tr>\n
CTC CellSearch<\/td>\nTube CellSave + EpCAM beads<\/td>\nCirculating tumor cells<\/td>\nA1 + B + magn\u00e9tico<\/td>\n<\/tr>\n
PCR digital QX200<\/td>\nMicroc\u00e1psula 20.000 droplets<\/td>\nMutation absoluto<\/td>\nA4 + RAEE microfluidic<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A soma t\u00edpica \u00e9 entre R$ 25.000-58.000\/m\u00eas<\/strong> em PGRSS dedicado de diag molecular vs R$ 9.000-22.000<\/strong> em PGRSS gen\u00e9rico subdimensionado.<\/p>\n

A NGS Illumina + FoundationOne CDx + Guardant360: o procedimento de alt\u00edssima complexidade<\/h2>\n

A primeira camada do desafio \u00e9 a NGS. Padr\u00e3o setorial inclui (a) NGS Illumina NovaSeq X+<\/strong> R$ 1.5-3M equipamento + NextSeq 2000 R$ 350-700k + MiSeq R$ 150-300k + reagent cartridge + flow cell descart\u00e1vel R$ 4-50k\/run; (b) FoundationOne CDx<\/strong> Roche\/Foundation Medicine 324-gene comprehensive genomic profiling R$ 12-25k\/teste + bloco FFPE + LGPD gen\u00e9tico; (c) Guardant360 CDx<\/strong> Guardant Health 74-83 genes liquid biopsy ctDNA R$ 8-18k\/teste; (d) Tempus xR + xT<\/strong> + Caris MI Profile<\/strong> + NeoGenomics Comprehensive Profile<\/strong> + Veracyte Decipher<\/strong> alternativas; (e) bioinform\u00e1tica<\/strong> com 1-3TB\/paciente + servidor + cloud GCP\/AWS Genomics + criptografia AES-256.<\/p>\n

Hospital com 500-2.000 NGS\/ano \u00d7 R$ 12-25k = R$ 6-50M\/ano em NGS + bioinform\u00e1tica + LGPD + livro RBI. Como discutimos no post sobre PGRSS de patologia cl\u00ednica<\/a>, molecular \u00e9 estruturante.<\/p>\n

A liquid biopsy + ctDNA + MRD + CTC: o est\u00e1gio de medicina precis\u00e3o<\/h2>\n

A segunda camada \u00e9 a precis\u00e3o. Padr\u00e3o setorial inclui (a) ctDNA cell-free DNA cfDNA<\/strong> Guardant360 + Signatera Natera tumor-informed + Foundation Tracker + Roche AVENIO + Inivata RaDaR para liquid biopsy + early detection + recurrence monitoring; (b) MRD Minimal Residual Disease<\/strong> Adaptive clonoSEQ IGH\/TCR para LLA + Natera Signatera tumor-informed para CRC\/MAMA\/PULM\u00c3O + Foundation Tracker pan-cancer; (c) CTC Circulating Tumor Cells<\/strong> CellSearch Veridex + Parsortix Angle microfluidic + Vortex BioSciences + RareCyte; (d) multi-cancer early detection MCED<\/strong> Grail Galleri + Exact Sciences Cologuard + Bluestar Genomics + Freenome + Singlera; (e) DPYD + UGT1A1 + TPMT<\/strong> pharmacogenomics PGx para ajuste dose chemo.<\/p>\n

Hospital com 100-300 liquid biopsy\/MRD\/ano \u00d7 R$ 5-15k = R$ 500k-4.5M\/ano em precis\u00e3o + biomarker.<\/p>\n

A PCR digital + microarray + nanopore + CRISPR diagnostics: o est\u00e1gio inovador<\/h2>\n

A terceira camada \u00e9 o inovador. Padr\u00e3o setorial inclui (a) PCR digital dPCR<\/strong> Bio-Rad QX200 + Stilla Naica + ThermoFisher QuantStudio Absolute para mutation absoluto + low-frequency detection; (b) microarray Affymetrix Cytoscan + Illumina HumanCytoSNP<\/strong> + Agilent CGH; (c) long-read sequencing<\/strong> Oxford Nanopore MinION + PacBio Sequel IIe + Revio para isoform + structural variant; (d) CRISPR diagnostics SHERLOCK Cas13 + DETECTR Cas12<\/strong> + LAMP isothermal Sherlock detector portable; (e) spatial transcriptomics<\/strong> 10x Genomics Visium + Vizgen MERSCOPE + Akoya CODEX para tumor microambiente.<\/p>\n

Hospital com 50-200 dPCR + 30-100 long-read\/ano \u00d7 R$ 1-5k m\u00e9dio = R$ 80k-1.2M\/ano em inovador.<\/p>\n

Tr\u00eas perfis de PGRSS para diag molecular<\/h2>\n

PGRSS gen\u00e9rico subdimensionado.<\/strong> Sem cobertura espec\u00edfica para NGS + FoundationOne + ctDNA + LGPD gen\u00e9tico. Custo mensal R$ 9.000-22.000<\/strong>, efic\u00e1cia limitada.<\/p>\n

PGRSS dedicado intermedi\u00e1rio.<\/strong> Cobertura para PCR + NGS b\u00e1sico, sem FoundationOne + Guardant360 + MRD. Custo mensal R$ 22.000-42.000<\/strong>, efic\u00e1cia 100-200%.<\/p>\n

PGRSS dedicado completo diag molecular.<\/strong> NGS + FoundationOne CDx + Guardant360 + Signatera + CellSearch + dPCR + integra\u00e7\u00e3o com PGRSS de oncologia geral<\/a>. Custo mensal R$ 42.000-58.000<\/strong>, ROI 250-500%.<\/p>\n

Os tr\u00eas erros que aparecem em PGRSS diag molecular subdimensionado<\/h2>\n

O primeiro \u00e9 o subdimensionamento de LGPD gen\u00e9tico<\/strong>. NGS + FoundationOne + Guardant360 com dado gen\u00e9tico sens\u00edvel exigindo Lei 14.510 + Resolu\u00e7\u00e3o CFM 1.999 + criptografia AES-256.<\/p>\n

O segundo \u00e9 a aus\u00eancia de EPI BSL-2\/3 biosseguran\u00e7a<\/strong>. Lei 11.105 + macac\u00e3o Tyvek + cabine fluxo laminar + livro CTNBio se OGM.<\/p>\n

O terceiro \u00e9 a descarte de reagente cartridge NGS como Grupo D<\/strong>. Illumina TruSight + flow cell + reagent \u00e9 A4 + B + bioactive + RAEE.<\/p>\n

A regula\u00e7\u00e3o de PGRSS no Brasil est\u00e1 em fase de moderniza\u00e7\u00e3o t\u00e9cnica acelerada com diag molecular como prioridade. As institui\u00e7\u00f5es que estruturam PGRSS dedicado desde o in\u00edcio \u2014 alinhadas com calend\u00e1rio 2026 de compliance<\/a> \u2014 atravessam o crescimento sem solavanco. Para gestores que precisam alinhar com gest\u00e3o paralela industrial, o portal Seven Res\u00edduos sobre servi\u00e7os completos<\/a> traz a perspectiva integrada. A SBPC Sociedade Brasileira de Patologia Cl\u00ednica<\/a> \u00e9 refer\u00eancia t\u00e9cnica.<\/p>\n

Solicite cota\u00e7\u00e3o PGRSS de diag molecular<\/a><\/strong> \u2014 cap\u00edtulo dedicado a NGS Illumina NovaSeq X+\/NextSeq 2000\/MiSeq + reagente kit, FoundationOne CDx Roche + Guardant360 Guardant Health + Tempus xR + Caris MI Profile, ctDNA Signatera Natera + clonoSEQ Adaptive + Foundation Tracker, CTC CellSearch Veridex + Parsortix Angle, dPCR Bio-Rad QX200 + Stilla Naica + Oxford Nanopore + CRISPR diagnostics.<\/p>\n","protected":false},"excerpt":{"rendered":"

Diagn\u00f3stico molecular gera RSS espec\u00edfico \u2014 PCR, NGS, ctDNA, CTC, MRD. PGRSS dedicado.<\/p>\n","protected":false},"author":3,"featured_media":2167,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[3004,2385,3003,1931],"class_list":["post-2168","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance-legislacao","tag-ctc","tag-ctdna","tag-diagnostico-molecular","tag-ngs"],"_links":{"self":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/comments?post=2168"}],"version-history":[{"count":1,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2168\/revisions"}],"predecessor-version":[{"id":4308,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2168\/revisions\/4308"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media\/2167"}],"wp:attachment":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media?parent=2168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/categories?post=2168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/tags?post=2168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}